FERG.UK

12,200

-1.29%↓

FERG.UK

12,200

-1.29%↓

FERG.UK

12,200

-1.29%↓

FERG.UK

12,200

-1.29%↓

FERG.UK

12,200

-1.29%↓

Search

ConvaTec Group PLC

Open

SectorFinance

255.2 -0.31

Overview

Share price change

24h

Current

Min

251.6

Max

257.6

Key metrics

By Trading Economics

Income

79M

Sales

1.1B

P/E

Sector Avg

36.743

22.015

EPS

0.07

Dividend yield

1.96

Profit margin

7.059

Employees

10,489

EBITDA

251M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+21.14% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.96%

3.90%

Market Stats

By TradingEconomics

Market Cap

203M

5.3B

Previous open

255.51

Previous close

255.2

News Sentiment

By Acuity

50%

50%

223 / 542 Finance

ConvaTec Group PLC Chart

Past performance is not a reliable indicator of future results.

Related News

26 Feb 2025, 13:37 UTC

Market Talk

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

Peer Comparison

Price change

ConvaTec Group PLC Forecast

Price Target

By TipRanks

21.14% upside

12 Months Forecast

Average 314.25 GBX  21.14%

High 375 GBX

Low 282 GBX

Based on 8 Wall Street analysts offering 12 month price targets forConvaTec Group PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

8

Buy

0

Hold

0

Sell

Sentiment

By Acuity

223 / 542 Finance

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.